Early research (Phase 1)WithdrawnNCT00000856
What this trial is testing
A Phase I/II Pilot Treatment Study Of CSF Penetration And Response To Ganciclovir And Foscarnet In CMV Neurologic Disease.
Who this might be right for
EncephalopathyHIV InfectionsRadiculitis
National Institute of Allergy and Infectious Diseases (NIAID)